Publicacions en què col·labora amb JUAN PABLO RODRIGO TAPIA (3)

2019

  1. The SRC inhibitor dasatinib induces stem cell-like properties in head and neck cancer cells that are effectively counteracted by the mithralog EC-8042

    Journal of Clinical Medicine, Vol. 8, Núm. 8

2018

  1. FUS-CHOP Promotes Invasion in Myxoid Liposarcoma through a SRC/FAK/RHO/ROCK-Dependent Pathway

    Neoplasia (United States), Vol. 20, Núm. 1, pp. 44-56

2016

  1. Osteosarcoma: Cells-of-Origin, Cancer stem cells, and targeted therapies

    Stem Cells International, Vol. 2016